Download PDF
Thromb Haemost 2002; 87(02): 206-210
DOI: 10.1055/s-0037-1612974
Letters to the Editor
Schattauer GmbH

Factor VII Activity Is an Independent Predictor of Cardiovascular Mortality in Elderly Women of a Sicilian Population: Results of an 11-year Follow-up

D. Noto
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
,
C. M. Barbagallo
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
,
A. B. Cefalu
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
,
G. Cavera
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
,
M. Sapienza
2   Department of Geriatrics, Hospital “Villa Sofia”, Palermo
,
A. Notarbartolo
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
,
G. Davi’
3   Department of Medicine and Aging, University of Chieti, Italy
,
M. R. Averna
1   Department of Internal Medicine and Geriatrics, University of Palermo, Palermo
› Author Affiliations
Further Information

Publication History

Received 30 April 2001

Accepted after resubmission 05 November 2001

Publication Date:
13 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

The aim of the Epidemiological project “Ventimiglia di Sicilia” is to identify the cardiovascular risk factors in a Sicilian population with a low risk profile and healthy nutritional habits. The risk of cardiovascular mortality in older subjects (over 60 years of age) is presented for an 11 year follow-up. Females showed higher prevalence of diabetes mellitus, hypertension, obesity and higher levels of total, LDL and HDL cholesterol, factor VII activity and fibrinogen compared to males. Cardiovascular mortality was related to hypertension and obesity in males, to high factor VII activity, obesity and diabetes mellitus in females. In a Logistic Regression model the same variables were independently correlated to cardiovascular mortality with the exception of obesity. In conclusion, these findings suggest that in a population with a low risk profile, other factors, such as factor VII activity, may emerge as predictors of cardiovascular mortality.

Keywords

Epidemiology - cardiovascular disease - coagulation - lipoproteins - factor VII activity
 

  • References

  • 1 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 02. 533-7.
    PubMedGoogle Scholar
  • 2 Assmann G, Cullen P, Heinrich J, Schulte H. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Munster Heart Study (PROCAM): Prospective Cardiovascular Munster Study. Isr J Med Sci. 1996 32. 364-70.
    PubMedGoogle Scholar
  • 3 Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997 96. 1102-8.
    PubMedGoogle Scholar
  • 4 Cortellaro M, Boschetti C, Cofrancesco E. et al. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results. Arterioscler Thromb 1992; 12: 1063-70.
    CrossrefPubMedGoogle Scholar
  • 5 Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrieres J, Arveiler D, Juhan-Vague I. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction—the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost 1998; 80: 749-56.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Tracy RP, Bovill EG, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1995 15. 1269-79.
    PubMedGoogle Scholar
  • 7 Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-70.
    CrossrefPubMedGoogle Scholar
  • 8 Balleisen L, Bailey J, Epping P-H, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985; 54: 475-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Green FR, Kelleher C, Wilkes H, Temple A, Meade TW, Humphries SE. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
    CrossrefPubMedGoogle Scholar
  • 10 Iacoviello L, Castelnuovo AD, Knijff PD, D’Orazio A, Amore C, Arboretti R, Kluft C, Donati MB. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
    CrossrefPubMedGoogle Scholar
  • 11 Feng LiDa, Tofler HGeoffrey, Larson GMartin, O’Donnell JChristopher, Lipinska Izabella, Schmitz Christian, Sutherland APatrice, Johnstone TMichael, Muller EJames, D’Agostino BRalph, Levy Daniel, Lindpaintner Klaus. Factor VII Gene Polymorphism, Factor VII Levels, and Prevalent Cardiovascular Disease: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2000; 20 (02) 593-9.
    CrossrefPubMedGoogle Scholar
  • 12 Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S. et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996; 119: 119-27.
    CrossrefPubMedGoogle Scholar
  • 13 Doggen CJ, Manger CV, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 1998; 80: 281-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Averna MR, Barbagallo CM, Montalto G, Sapienza M, Pagano M, Cavera G, Rini GB, Di Fede G, Noto D, Settepani G, Pardo A, Descovich GC, Notarbartolo A. Progetto di epidemiologia e prevenzione “Ventimiglia di Sicilia”: Dati di popolazione. Giorn Arterioscl 1992; 17: 83-7.
    PubMedGoogle Scholar
  • 15 Averna MR, Barbagallo CM, Montalto G, Sapienza M, Cavera G, Rini GB, Pardo A, Descovich GC, Notarbartolo A. Distribuzione dei lipidi e delle apoproteine plasmatiche e prevalenza di dislipidemie. Giorn Arterioscl 1995; 20: 29-35.
    PubMedGoogle Scholar
  • 16 Noto D, Barbagallo CM, Cavera G, Caldarella R, Marino G, Pace A, Notarbartolo A, Averna MR. Lipoprotein(a) levels and apoprotein(a) phenotypes in a sicilian population. Ann Ital Med Int 1998; 13: 205-8.
    PubMedGoogle Scholar
  • 17 Barbagallo CM, Cavera G, Sapienza M, Noto D, Cefalu’ AB, Pagano M, Montalto G, Notarbartolo A, Averna MR. Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality. The Ventimiglia di Sicilia project. Int J Obes 2001; 25: 185-90.
    CrossrefPubMedGoogle Scholar
  • 18 Noto D, Barbagallo CM, Cavera G, Cefalu’ AB, Caimi G, Marino G, Lo LCoco, Caldarella R, Notarbartolo A, Averna MR. Leukocyte Count, Diabetes Mellitus and Age are strong predictors of Stroke in a Rural Population of Southern Italy: a eight years Follow-up. Atherosclerosis. 2001 in press.
    PubMedGoogle Scholar
  • 19 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-83.
    PubMedGoogle Scholar
  • 20 Roschlau P. Enzymatische Bestimmung des Gesamte-cholesterins im Serum. Chem Klin Biochem 1974; 12: 226-7 (in German).
    PubMedGoogle Scholar
  • 21 Wahalefeld AW. Triglyceride determination after enzymatic hydrolysis. in Methods of enzymatic analysis. edited by Bergmeyer HU. New York: Academic Press; 1974. 04 1831-35 (in German).
    Google Scholar
  • 22 Lopez-Virella HF, Stone P, Ellis J, Coltwell LA. Cholesterol determination in the HDL separated by precipitation with polianions. J Lipid Res 1970; 11: 583-95.
    PubMedGoogle Scholar
  • 23 Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-3.
    PubMedGoogle Scholar
  • 24 Becker W, Schafer W, Ziebenbein W. Standardization of immunochemical quantitation of human apolipoprotein A and B. La Ricerca Clin Lab 1980; 10: 203-12.
    CrossrefPubMedGoogle Scholar
  • 25 Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59 (02) 249-58.
    CrossrefPubMedGoogle Scholar
  • 26 Kario K, Matsuo T. High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system. J Cardiovasc Risk 1994; 01: 165-71.
    CrossrefPubMedGoogle Scholar
  • 27 Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-80.
    CrossrefPubMedGoogle Scholar
  • 28 Moor E, Silveira A, van’t FHooft, Suontaka AM, Eriksson P, Blomback M, Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995 15. 655-64.
    PubMedGoogle Scholar
  • 29 Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study, Cardiovascular Health Study Investigators. Am J Epidemiol. 1996 143. 665-76.
    PubMedGoogle Scholar
  • 30 Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity: a predictor of cardiovascular mortality. Atherosclerosis. 1986 60. 269-77.
    PubMedGoogle Scholar
  • 31 Miller GJ, Stirling Y, Howarth DJ, Cooper JC, Green FR, Lane A, Humphries SE. Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 1995; 73: 893.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000; 102: 2816-22.
    CrossrefPubMedGoogle Scholar